Pacific Biosciences Of California (PACB)
Deferred Revenue
$16.10M
Quarterly · Period ending: · USD
PACB Deferred Revenue
Latest reported$16.10Mperiod ending
Latest reported$16.10Mperiod ending
PACB Quarterly Deferred Revenue ($0.00 → $16.10M)
Quarterly deferred revenue
High-resolution chart · PNG
PACB deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 16,103,000 | |
| 16,329,999 | |
| 0 | |
| 0 | |
| 14,863,000 | |
| 15,241,000 | |
| 13,864,000 | |
| 17,292,000 | |
| 19,212,000 | |
| 17,346,000 | |
| 16,342,000 | |
| 22,372,000 | |
| 24,983,000 | |
| 30,866,000 | |
| 30,498,000 | |
| 30,689,000 | |
| 32,084,000 | |
| 12,729,000 | |
| 10,977,000 | |
| 9,773,000 | |
| 9,534,000 | |
| 9,607,000 | |
| 8,722,000 | |
| 104,982,000 | |
| 104,932,000 | |
| 105,107,000 | |
| 7,610,000 | |
| 6,379,000 | |
| 6,707,000 | |
| 6,428,000 | |
| 6,537,000 | |
| 5,740,000 | |
| 6,416,000 | |
| 5,993,000 | |
| 6,319,000 | |
| 6,151,000 | |
| 6,782,000 | |
| 6,683,000 | |
| 7,130,000 | |
| 6,571,000 | |
| 10,667,000 | |
| 13,631,000 | |
| 17,637,000 | |
| 20,688,000 | |
| 20,892,000 | |
| 20,639,000 | |
| 12,906,000 | |
| 12,092,000 | |
| 12,059,000 | |
| 10,689,000 | |
| 10,831,000 | |
| 4,234,000 | |
| 3,347,000 | |
| 2,961,000 | |
| 3,378,000 | |
| 3,555,000 | |
| 4,170,000 | |
| 3,920,000 | |
| 6,583,000 | |
| 4,786,000 | |
| 2,381,000 | |
| 4,350,000 | |
| 3,221,000 | |
| 1,052,000 | |
| -61,000 | |
| 0 |